心脏骤停治疗中心在目标温度管理期间镇静与镇痛剂量的差异
该研究基于国际多中心TTM试验(950例随机分至33°C或36°C,36个ICU),分析18个中心614例患者镇静镇痛剂量差异。丙泊酚(70%)和芬太尼(51%)最常用,咪达唑仑等效剂量平均0.13(0.07, 0.22)mg/kg/h,芬太尼等效剂量1.16(0.49, 1.81)µg/kg/h。各中心药物数量、平均剂量及所有时间点滴定均存在显著差异(p < 0.001),多因素分析显示48小时较高剂量(p = 0.003, OR 1.75)、24-48小时镇痛滴定增加(p = 0.005, OR 4.89)与5天后觉醒相关,24-48小时镇静滴定增加与5天后觉醒(p < 0.001, OR > 100)及临床癫痫发作(p = 0.04, OR 240)相关,镇痛滴定减少与6个月生存相关(p = 0.048)。作者认为剂量与滴定和延迟觉醒、癫痫发作及生存相关,但因果关系无法证明。
要点
- 各中心在药物数量、平均剂量及所有时间点滴定上均存在显著差异(p < 0.001)。
- 多因素分析中,48小时较高剂量与5天后觉醒相关(p = 0.003, OR 1.75)。
- 24-48小时镇痛滴定增加与5天后觉醒相关(p = 0.005, OR 4.89)。
- 24-48小时镇静滴定增加与5天后觉醒相关(p < 0.001, OR > 100),且与临床癫痫发作发生率更高相关(p = 0.04, OR 240)。
- 多因素分析中,镇痛滴定减少与6个月生存显著相关(p = 0.048)。
适用人群与场景
- 国际TTM试验中36个ICU的950例心脏骤停复苏后患者,随机分至33°C或36°C目标温度管理。
- 本分析纳入其中18个中心的614例患者。
处置流程与药物剂量
- 镇静镇痛药物以丙泊酚(70%)和芬太尼(51%)最常用。
- 咪达唑仑等效剂量平均为0.13(0.07, 0.22)mg/kg/h,芬太尼等效剂量平均为1.16(0.49, 1.81)µg/kg/h。
- 在12、24、48小时记录镇静镇痛药物累积剂量,并归一化为咪达唑仑和芬太尼等效剂量。
研究设计与关键结果
- 研究类型:国际多中心TTM试验的子分析,纳入18个中心614例患者。
- 药物使用:丙泊酚70%,芬太尼51%最常用;咪达唑仑等效剂量平均0.13(0.07, 0.22)mg/kg/h,芬太尼等效剂量平均1.16(0.49, 1.81)µg/kg/h。
- 各中心间药物数量、平均剂量及所有时间点滴定均存在显著差异(p < 0.001),但12-24小时镇静滴定差异无统计学意义(p = 0.40)。
- 多因素分析:48小时较高剂量与5天后觉醒相关(p = 0.003, OR 1.75);24-48小时镇痛滴定增加与5天后觉醒相关(p = 0.005, OR 4.89)。
- 多因素分析:24-48小时镇静滴定增加与5天后觉醒相关(p < 0.001, OR > 100),且与临床癫痫发作发生率更高相关(p = 0.04, OR 240)。
- 多因素分析:镇痛滴定减少与6个月生存显著相关(p = 0.048)。
证据类型、等级与局限
- 证据类型:国际多中心随机对照试验(TTM试验)的子分析。
- 作者结论:镇静镇痛剂量与滴定和延迟觉醒、临床癫痫发作发生率及生存相关,但这些发现的因果关系无法证明。
- 局限:原文未报告局限性。
对床旁实践的改变
- 各中心镇静镇痛药物选择、剂量及滴定存在显著差异,提示当前实践异质性大。
- 剂量与滴定和延迟觉醒、临床癫痫发作及6个月生存相关,但因果关系无法证明;作者认为因果关系不能证实。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Sedation and analgesia are recommended during targeted temperature management (TTM) after cardiac arrest, but there are few data to provide guidance on dosing to bedside clinicians. We evaluated differences in patient-level sedation and analgesia dosing in an international multicenter TTM trial to better characterize current practice and clinically important outcomes.
METHODS: A total 950 patients in the international TTM trial were randomly assigned to a TTM of 33 °C or 36 °C after resuscitation from cardiac arrest in 36 intensive care units. We recorded cumulative doses of sedative and analgesic drugs at 12, 24, and 48 h and normalized to midazolam and fentanyl equivalents. We compared number of medications used, dosing, and titration among centers by using multivariable models, including common severity of illness factors. We also compared dosing with time to awakening, incidence of clinical seizures, and survival.
RESULTS: A total of 614 patients at 18 centers were analyzed. Propofol (70%) and fentanyl (51%) were most frequently used. The average dosages of midazolam and fentanyl equivalents were 0.13 (0.07, 0.22) mg/kg/h and 1.16 (0.49, 1.81) µg/kg/h, respectively. There were significant differences in number of medications (p < 0.001), average dosages (p < 0.001), and titration at all time points between centers (p < 0.001), and the outcomes of patients in these centers were associated with all parameters described in the multivariate analysis, except for a difference in the titration of sedatives between 12 and 24 h (p = 0.40). There were associations between higher dosing at 48 h (p = 0.003, odds ratio [OR] 1.75) and increased titration of analgesics between 24 and 48 h (p = 0.005, OR 4.89) with awakening after 5 days, increased titration of sedatives between 24 and 48 h with awakening after 5 days (p < 0.001, OR > 100), and increased titration of sedatives between 24 and 48 h with a higher incidence of clinical seizures in the multivariate analysis (p = 0.04, OR 240). There were also significant associations between decreased titration of analgesics and survival at 6 months in the multivariate analysis (p = 0.048).
CONCLUSIONS: There is significant variation in choice of drug, dosing, and titration when providing sedation and analgesics between centers. Sedation and analgesia dosing and titration were associated with delayed awakening, incidence of clinical seizures, and survival, but the causal relation of these findings cannot be proven.
参考来源
- Ceric A, May TL, Lybeck A, et al. Cardiac Arrest Treatment Center Differences in Sedation and Analgesia Dosing During Targeted Temperature Management. Neurocrit Care. 2022. PMID: 35896768. doi:10.1007/s12028-022-01564-6
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。